NDC properties for NDC 9 0440-2505
NDC item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
NDC item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
NDC item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | ACTIVE |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
NDC item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
NDC item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
NDC item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
NDC item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
NDC item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
NDC item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
NDC item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
NDC item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
NDC item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |